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AGGGGCCexpansionwithin an intronic region of the
C9orf72 gene forms RNA foci that are associated
with one-third of familial amyotrophic lateral scle-
rosis and one-quarter of frontotemporal dementia.
The C9orf72 locus also expresses an antisense tran-
script with a CCCCGG expansion that forms foci and
may contribute to disease. Synthetic agents that
bind these hexanucleotide repeats and block foci
would be leads for therapeutic discovery. We have
engineered duplexRNAs to enable them to recognize
difficult C/G targets. Recognition inhibits foci formed
by both GGGGCC and CCCCGG RNA. Our findings
show that a single duplex RNA can be used to recog-
nize both disease-related C9orf72 transcripts. More
broadly, we extend RNAi to previously inaccessible
C/G sequences and provide another example of
target recognition in human cells by nuclear RNAi.
INTRODUCTION
An expanded hexanucleotide repeat has been implicated in
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia
(FTD). This repeat expansion occurs in the first intron of the chro-
mosome 9 open reading frame 72 (C9orf72) gene. It accounts for
one-third of familial ALS and one-quarter of familial FTD (Renton
et al., 2011; DeJesus-Hernandez et al., 2012). The sequence of
the repeat within C9orf72 pre-mRNA is GGGGCC. Patients
with ALS or FTD typically have one mutant C9orf72 allele that
contains 700–1,600 repeats, while unaffected individuals have
fewer than 24 repeats in both alleles (DeJesus-Hernandez
et al., 2012). The C9orf72 locus also expresses an antisense
transcript that encodes a CCCCGG repeat that may contribute
to disease (Gendron et al., 2013).
Expanded repeats may form structures that disrupt normal
RNA-protein interactions, affect RNA processing, and contribute
to pathogenesis (Ling et al., 2013). The expanded sense and
antisense RNA transcripts are C/G rich, and the G-rich sense
strand is known to form a stable G-quadruplex structure (Haeus-
ler et al., 2014). The expanded repeats and the structures they
form may sequester proteins and disrupt normal function byChemistry & Biology 22, 1505–151decreasing the effective concentrations of associated proteins
within cells (Lee et al., 2013). A similar mechanism of action
has been demonstrated for the expanded CUG repeats that
occur with the mutant DM protein kinase gene responsible for
myotonic dystrophy (Wheeler et al., 2009; Sobczak et al.,
2013). Because of their potential to disrupt normal processes
in cells and contribute to disease, both the sense and antisense
repeat transcripts at the C9orf72 locus are targets for inhibitors
that block RNA, disrupt structure, and alter the potential for
RNA-protein interactions.
Both ALS and FTD are currently incurable, leading to an urgent
need for new insights into treatment. One strategy to blunt the
impact of mutant C9orf72 RNA is to inhibit expression of the
gene. Antisense oligonucleotides that are complementary to in-
tronic regions within the C9orf72 transcript have been tested.
These oligonucleotides were designed to recruit RNaseH to their
target sites and lead to degradation of intronic RNA. Introduction
of these oligonucleotides into cells caused foci formation to
decrease, and reduced RNA toxicity (Donnelly et al., 2013;
Lagier-Tourenne et al., 2013; Sareen et al., 2013). In this report,
we investigate whether duplex RNAs can also block foci forma-
tion and whether a single duplex RNA can interfere with foci
formed by both the sense GGGGCC transcript and the antisense
CCCCGG transcript. Duplex RNAs would have the advantage of
using the potent RNAi mechanism and inhibiting both transcripts
with one agent.
We hypothesized that duplex RNAs complementary to the
expanded repeat would target the GGGGCC and CCCCGG
repeats simultaneously. Previous work had shown that it
was possible to use duplex RNAs to target expanded trinucleo-
tide repeats. Our laboratory and others had previously devel-
oped engineered duplex RNAs that target genes containing
expanded CAG trinucleotide repeats (Hu et al., 2010; Fiszer
et al., 2011).
The C9orf72 GGGGCC or CCCCGG repeats, however, pose
novel challenges to recognition that go beyond past experience
targeting CAG repeats. One challenge is that, unlike CAG re-
peats, the GGGGCC repeat is intronic rather than within an
exon. The GGGGCC and CCCCGG foci are detected in cell
nuclei, rather than the cytoplasm. A second challenge, therefore,
is that recognition by duplex RNA would need to occur in cell
nuclei and involve nuclear RNAi rather than the more familiar
cytoplasmic RNAi mechanism.
A third challenge is that RNA duplexes with high C/G content
are considered to be poor candidates for gene silencing by1, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1505
Table 1. siRNAs Targeting the Hexanucleotide Repeat
No. Sequence (AS, 50-30; S, 30-50) Mismatch Number Duplex Tm (C)
% Inhibition
G-Rich Foci
% Inhibition
C-Rich Foci
R1 CGGCCCCGGCCCCGGCCCCdTdT (AS)
dTdTGCCGGGGCCGGGGCCGGGG (S)
0 >87 NI 8
R2 CGGCCCCGGAACCGGCCCCdTdT (AS)
dTdTGCCGGGGCCUUGGCCGGGG (S)
10, 11 >87 18 –
R3 CGGCCCCGAAACCGGCCCCdTdT (AS)
dTdTUCCGGGGCUUUGGCCGGGG (S)
9, 10, 11 >87 73 58
R4 CGGCCCCGAAAACGGCCCCdTdT (AS)
dTdTUCCGGGGCUUUUGCCGGGG (S)
9, 10, 11, 12 >87 52 48
R5 CGGCCCCAAAAACGGCCCCdTdT (AS)
dTdTUCCGGGGCUUUUGCCGGGG (S)
8, 9, 10, 11, 12 83.7 43 –
R6 CGGCCCCGAAAACGACCCCdTdT (AS)
dTdTUCCGGGGCUUUUGCCGGGG (S)
9, 10, 11, 12, 15 83.1 54 –
R7 CGGCCCCGAAAACGACCACdTdT (AS)
dTdTUCCGGGGCUUUUGCCGGGG (S)
9, 10, 11, 12, 15, 18 76.2 32 –
R8 CGGCCCCGAACCAGGACCCdTdT (AS)
dTdTUCCGGGGCUUGGUCCUGGG (S)
9, 10, 13, 16 (AS) >87 65 –
R9 CGGCCCCGAACCAGACCCCdTdT (AS)
dTdTUCCGGGGCUUGGUCCUGGG (S)
9, 10, 13, 15 (AS) 84.0 78 –
R10 CGGCCCCGAAACCGACCCCdTdT (AS)
dTdTUCCGGGGCUUUGGCCGGGG (S)
9, 10, 11, 15 (AS) 86.7 72 –
R11 CGGCCCCGAACCCGACCCCdTdT (AS)
dTdTUCCGGGGCUUGGGCUGGGG (S)
9, 10, 15 (AS) >87 55 –
R12 CGGCCCCGAAACCGACCCCdTdT (AS)
dTdTUCCGAGGCUUUGGCCGGGG (S)
9, 10, 11, 15, 19 (S) 77.3 – 62
R13 CGGCCCCGAAACCGGCCCUdTdT (AS)
dTdTGCCGAGGCUUUGGCCGGGG (S)
9, 10, 11, 15 (S) 84.3 – 45
R14 CGGCCCCGAAACCGGCCCUdTdT (AS)
dTdTGCCGAGACCUUGGCCGGGG (S)
9,10,13,15 (S) 70.8 – 46
Control siRNA
C1 GCUAUACCAGCGUCGUCAUdTdT (AS)
dTdTCGAUAUGGUCGCAGCAGUA (S)
– – NI NI
C2 CGGAAACGGCCCCGGCCCCdTdT (AS)
dTdTGCCUUUGCCGGGGCCGGGG (S)
4,5,6 (AS)
Seed mismatch
>87 NI –
C3 CGGACACGAAACCGGCCCCdTdT(AS)
dTdTUCCUGUGCUUUGGCCGGGG (S)
4, 6, 9, 10, 11 (AS)
Seed mismatch
>87 NI –
C4 CCGCCGGGAAACGGCCCGGdTdT(AS)
dTdTUGCGGCCCUUUGCCGGGCC (S)
9, 10, 11 (AS)
Scrambled/mismatch
>87 NI –
C5 CGGCCCCGGCCCCAAACCCdTdT (AS)
dTdTGCCGGGGCCGGGGUUUGGG (S)
4, 5, 6 (S)
Seed mismatch
>87 – NI
C6 CGGCCACGAACCCAAACCCdTdT (AS)
dTdTGCCGGGGCCGGGGUUUGGG (S)
4, 5, 6 (S)
Seed mismatch
71.9 – NI
C7 GCAGCUGUUGCUACUGUUGdTdT (AS)
dTdTCGUCGACAACGAUGACAAC (S)
– – NI NI
C8 CAGACAAUGAUUCACACGGdTdT (AS)
dTdTGUCUGUUACUAAGUGUGCC (S)
– – NI NI
E1 UGGAAUAAUACUCUGACCCdTdT (AS)
dTdTACCUUAUUAUGAGACUGGG (S)
– – – –
Bases that are mismatched relative to the GGGGCC/CCCCGG repeat are in boldface and underlined. NI, no significant inhibition detected; , not
measured.RNAi (Petri and Meister, 2013). High C/G content impairs both
strand loading and target recognition. RNA duplexes that are
C/G rich will not readily unwind to release the RNA guide strand.
Target RNA transcripts that are C/G rich are likely to form strong1506 Chemistry & Biology 22, 1505–1511, November 19, 2015 ª2015secondary structures that will resist binding by complementary
small RNAs.
Here, we demonstrate that these challenges can be over-
come. We show that duplex RNAs can be engineered toElsevier Ltd All rights reserved
Figure 1. Sense and AntisenseNuclear RNA
Foci Are Detected in C9orf72 Patient-
Derived Fibroblast Cells
(A) Scheme showing duplex RNAs targeting sense
and antisenseC9orf72 transcripts and the location
of the expanded CCCCGG or GGGGCC repeat
regions.
(B) FISH images of expanded GGGGCC or
CCCCGG RNA foci in wild-type control fibroblasts
or C9orf72 patient-derived fibroblasts. A (CAG)10-
Cy5 probe complementary to a CUG repeat was
used as a control in C9orf72 fibroblasts.overcome the barriers of high G/C content, function inside cell
nuclei, recognize GGGGCC and CCCCGG repeats, and inhibit
both sense and antisense strand foci.
RESULTS AND DISCUSSION
Engineering Duplex RNAs to Recognize C/G-Rich
Sequences
Duplex RNAs intended for gene silencing consist of a guide
strand complementary to the target RNA and a passenger strand
that is complementary to the guide strand. Because duplex
RNAs have two strands, a single duplex RNA has the capacity
to recognize a sequence within an mRNA and a sequence within
a corresponding antisense transcript. The challenge for recogni-
tion of GGGGCC/CCCCGG repeats is the likelihood that a C/G
duplex will be unable to enter the RNAi-induced silencing com-
plex (RISC) because the parent duplex will be too stable.
AGO2 is the catalytic engine of RNAi (Liu et al., 2004) that
drives cleavage of target RNAs when sequences are fully com-
plementary. AGO2 can, however, also promote recognition of
mismatched sequences. For example, microRNAs that occur
naturally supply an endogenous gene-silencing mechanism
that typically involves duplex RNAs that are mismatched rela-
tive to their mRNA targets. The introduction of mismatches
into the central region of the RNA duplex eliminates the poten-
tial for substrate cleavage by AGO2 while continuing to permit
the guide RNA strand to recognize the target site (Wang et al.,
2008).
We have previously tested duplex anti-CAG RNAs with central
mismatches as inhibitors of huntingtin, ataxin-3, and atrophin-1
expression (Hu et al., 2014).We found that these duplexes do not
promote cleavage of their targets but can be potent and allele-
selective inhibitors of protein expression. We reasoned that the
introduction of central mismatches into the C/G-rich duplex
RNA between bases 8 and 12 would reduce the affinity of the
RNA duplex, increase the potential for the two strands to disso-
ciate from one another, and make it more likely that the strands
could enter into a complex with AGO2.Chemistry & Biology 22, 1505–1511, November 19, 2015 ªDuplex RNAs Inhibit GGGGCC and
CCCCGG Foci
We tested the ability of RNA duplexes
(Table 1) to inhibit foci. Duplex RNA R1
(R = repeat-targeted) was fully comple-
mentary to the C/G-rich repeat. All other
duplex RNAs contained A or U substitu-tions. RNA R1 has a measured melting temperature (Tm) of
>87C. Somemodified RNAswith two, three, or fourmismatches
also had Tm values >87
C. RNAs with more than four mis-
matches had Tm values as low as 70.8
C. RNAs C1–C6 (C = con-
trol) were mismatched within their critical ‘‘seed’’ regions (bases
2–8) or scrambled duplexes. RNA E1 (E = exonic) was fully com-
plementary to exon 4 and was used as a positive control for
transfection efficiency.
We introduced anti-GGGGCC/CCCCGG duplex RNAs (Fig-
ure 1A and Table 1) into ALS patient-derived fibroblast cells by
transfection with cationic lipid. Two days after transfection we
used fluorescent in situ hybridization (FISH) followed by analysis
using fluorescent microscopy to monitor both CCCCGG and
GGGGCC foci (Figure 1B). Hundreds of cells were analyzed for
each treatment to permit accurate quantitation of the number
of cells containing at least one foci and the number of foci per
100 cells.
After establishing the FISH detection assay, we tested duplex
RNAs for their ability to affect foci. Fully complementary duplex
RNA R1 did not affect the total number of cells containing
GGGGCC foci, nor did it reduce the number of foci per cell (Fig-
ure 2A). This result is consistent with the expectation that an
entirely C/G duplex would be too stable to enter the RISC.
Duplex R2, which contained two A/U substitutions, also did not
significantly affect foci.
We hypothesized that two mismatches may have been insuffi-
cient, and tested duplexes with three to six mismatches relative
to the target G-rich strand. Duplexes R3, R4, R5, and R6 reduced
the number of cells withGGGGCC foci and the number of foci per
100 cells, demonstrating the potential for duplexes to inhibit foci
(Figures 2A and 2B). Duplex R7 with six mismatches relative to
the target G-rich strand did not significantly inhibit foci, suggest-
ing a limit to the number of substitutions that could be tolerated.
We also tested duplexes R1, R3, and R4 for inhibition of foci
formed by the C-rich antisense transcript. Similar to the outcome
we had observed for the G-rich strand, complementary duplex
R1 did not reduce foci detection (Figure 2C). Duplexes R3 and
R4 reduced both the total number of cells with C-rich foci and2015 Elsevier Ltd All rights reserved 1507
Figure 2. Inhibition of GGGGCC or
CCCCGG Foci by Duplex RNAs Evaluated
by Fluorescent Microscopy
(A) Effect of duplex RNAs on detection of
expanded GGGGCC repeat RNA with C9orf72
intronic RNA.
(B) Sample microscopy images used for evalu-
ating GGGGCC C9orf72 sense foci.
(C) Effect of duplex RNAs on detection of
expanded CCCCGGC9orf72 antisense transcript.
(D) Sample microscopy images used for evalu-
ating CCCCGG C9orf72 antisense foci.
Error bars represent SEM. *p < 0.05; **p < 0.01;
***p < 0.001 compared with control C1. At least
100 cells were analyzed for each experiment. The
yellow arrowheads point to cells containing foci.the number of foci per cell (Figures 2C and 2D). For duplexes R3–
R12 we had introduced a 30 U substitution into the 30-sense
strand to bias loading toward the antisense strand (Schwarz
et al., 2003; Malefyt et al., 2014). Duplexes R3 and R4 that con-
tained this substitution inhibited both the G-rich and C-rich foci.
It is possible that standard rules for optimizing RNA duplexes are
less powerful in the context of atypical C/G-rich duplexes.
After demonstrating inhibition of both G-rich and C-rich foci by
duplex RNAs, we tested whether it would be possible to improve
potency by redesigning the RNA sequences. We evaluated the
effect of adding mismatches outside the central region of the
duplex (Table 1). Duplexes R8, R9, R10, and R11 were all potent
inhibitors of G-rich foci formation (Figure 3A). We also examined
duplexes R12, R13, and R14 that preserved seed-sequence
complementarity toward the C-rich sequence. R13 and R14
had a 30 U substitution to bias loading recognition toward
the C-rich target. We found that each of these RNAs were
effective inhibitors of C-rich foci (Figure 3B). We did not observe
a correlation between reduced Tm value and efficacy, presum-
ably because even the lowest mismatch-containing duplex
possessed a value greater than 70C.1508 Chemistry & Biology 22, 1505–1511, November 19, 2015 ª2015 Elsevier Ltd All rights reTo further evaluate inhibition of foci by
RNA duplexes, we examined inhibition
as a function of time. Significant reduc-
tions in sense G-rich and antisense
C-rich foci were observed 8–12 days after
transfection (Figure 3C). The fibroblast
cells divide every 2–3 days, and reduced
efficacy is similar to that typically
observed in our laboratory when using
duplex RNAs.
Efficient gene silencing by duplex
RNAs requires complementarity between
the guide strand and the RNA target at
bases 2 through 8, a region known as
the seed sequence. To begin to test the
mechanism of anti-GGGGCC/CCCCGG
duplex RNAs, we introducedmismatches
into the seed sequence. We tested
noncomplementary control RNAs C1,
C7, and C8, seed mismatched RNAs
C2, C3, C5, C6, and scrambled duplexC4. We observed that duplexes with altered seed sequences
did not inhibit sense or antisense foci (Figures 4A and 4B). Pre-
venting foci inhibition by disrupting seed-sequence complemen-
tarity is consistent with function through the RNAi machinery. We
tested other noncomplementary or scrambled duplex RNAs, and
these also did not affect foci formation, also consistent with inhi-
bition being an ‘‘on-target’’ effect through direct Watson-Crick
interaction with the expanded GGGGCC or CCCCGG targets.
Because AGO2 is a key component in RNAi (Liu et al., 2004),
we used RNA immunoprecipitation (RIP) to determine whether
our repeat-targeted RNAs were recruiting AGO2 for recognition
of GGGGCC repeats within C9orf72 intronic RNA. Our RIP
experiment employed an antibody that recognizes endoge-
nously expressed AGO2, and detection employed PCR primers
designed to amplify intron 1 RNA downstream of the GGGGCC
repeat. RIP revealed that addition of RNA R3 promoted associ-
ation of AGO2 with intronic C9orf72 RNA (Figures 4C and 4D).
Sequencing confirmed that the RIP product was derived from
C9orf72 intronic RNA (Figure 4E).
Introduction of central mismatches relative to a target RNA is
predicted to eliminate cleavage by AGO2 (Wang et al., 2008).served
Figure 3. Optimizing Inhibition of GGGGCC
and CCCCGG Foci
(A) Inhibition of GGGGCC foci by optimized duplex
RNAs.
(B) Inhibition of optimized CCCCGG foci by opti-
mized duplex RNAs.
(C) Time course showing effect of duplex RNA on
foci number and foci per cell.
Error bars represent SEM. *p < 0.05; **p < 0.01;
***p < 0.001 compared with control C1. At least
100 cells were analyzed for each experiment.To determine the effect of these mismatches on C9orf72
mRNA and intron 1 RNA, we examined transcript levels by
qPCR. Levels of both the mRNA (Figure 4F) and intron 1 RNA
(Figure 4G) were unchanged after treatment with various
mismatch-containing repeat-targeted duplex RNAs. By con-
trast, fully complementary positive control duplex E1 effi-
ciently silenced C9orf72 expression. These results are consis-
tent with a mechanism of action that does not require slicer
activity and with the conclusion that inhibiting foci formation
does not require RNAi-mediated silencing of C9orf72. RNA
levels remain constant, and inhibition of foci is most likely
due to binding of the RNA duplexes to the C-rich or G-rich
transcripts.
SIGNIFICANCE
The discovery of a linkage between the GGGGCC repeat
expansion within intronic C9orf72 RNA and ALS/FTD was
important because it is the most common inherited marker
for these two diseases. There are currently no curative
treatments for either disease, and agents that could slow
disease progress would help satisfy a major unmet medical
need. Application of anti-GGGGCC or anti-CCCCGG RNAs
reduced detection of RNA foci by 40%–60%. The sense
and antisense transcripts derived from themutant expanded
hexanucleotide repeat have the potential to contribute to
disease. Our data suggest that duplex RNAs can be de-
signed such that a single RNA can block both strands. While
we did not test all duplexes for inhibition of both G-richChemistry & Biology 22, 1505–1511, November 19, 2015 ªand C-rich foci, the duplexes are
similar and we would expect similar
outcomes.
It is difficult to directly compare this
work with previous studies (Donnelly
et al., 2013; Lagier-Tourenne et al.,
2013) because the antisense oligonu-
cleotides used are not commercially
available. Even without a direct com-
parison, there are two clear advan-
tages of our approach. The first is
that our duplexes function through
the RNAi pathway, rather than the
using ASOs that act by recruiting
RNase H. This opens up the prospect
of using a silencing mechanism that
exploits the high potency of RNAi.The second advantage is that our duplex RNAs inhibit both
G-rich and C-rich foci. For example, one of the papers
(Lagier-Tourenne et al., 2013) tested ASOs for C-rich foci
and found no inhibition.
RNAi is a commonly used technique, but highly C/G-
rich sequences are often thought to be off limits because
of the high stability of structure formation. Our results
demonstrate that sequences composed entirely of C
and G can be recognized by manipulating the presence of
mismatched bases to tailor affinity. This finding widens
the pool of cellular RNA sequences that can be accessed
by RNAi and increases the potential to control gene
expression. C9orf72 foci are located in human cell nuclei,
and their inhibition by duplex RNAs provides another
example of the power of nuclear RNAi to control gene
expression.
EXPERIMENTAL PROCEDURES
Cell Culture and Small Interfering RNA Transfection
Mutant expanded repeat C9orf72 patient-derived fibroblast cell line is a gift
from Dr. John Ravits of UCSD. The fibroblasts were maintained at 37C and
5%CO2 in Eagle’s minimum essential medium (MEM) (Sigma, M4655) supple-
mented with 15% heat-inactivated fetal bovine serum (Sigma) and 0.5%MEM
nonessential amino acids (Sigma).
Small interfering RNAs (siRNAs) were obtained from IDT. Double-stranded
RNAs were prepared by annealing the two RNA strands in 2.53 PBS solutions.
siRNAs were transfected into cells with lipid RNAiMAX (Life Technologies) as
previously described (Hu et al., 2010). For qPCR analysis, cells were plated
at a density of 80,000 per well of a 6-well plate 48 hr before transfection. Cells
were typically harvested 2 days after transfection.2015 Elsevier Ltd All rights reserved 1509
Figure 4. Involvement of RNAi
(A) Inhibition of GGGGCC foci is seed-sequence
dependent.
(B) Inhibition of CCCCGG foci is seed-sequence
dependent. At least 100 cells were analyzed for
each experiment in (A) and (B).
(C) RNA immunoprecipitation demonstrates
recruitment of AGO2 toC9orf72 intronic RNA upon
addition of duplex RNA.
(D) Quantitation of enrichment of AGO2 on
C9orf72 intronic RNA.
(E) Sequencing of amplified product from RIP
confirms identity as C9orf72 intronic RNA.
(F) qPCR showing effect of duplex RNAs on
C9orf72 mRNA levels.
(G) qPCR showing effect of duplex RNAs on levels
of C9orf72 intron 1 RNA.
Error bars represent SEM. *p < 0.05; **p < 0.01;
***p < 0.001 relative to treatment with noncom-
plementary control RNA C1. NT, no treatment.qPCR Analysis
Total RNA from fibroblast cells was extracted using TRIzol agent (Invitrogen).
Samples were then treated with DNase I at 25C for 10min. Reverse transcrip-
tion reactions were done using a High-Capacity Reverse Transcription Kit
(Applied Biosystems) according to the manufacturer’s protocol.
C9orf72 expression was analyzed by qPCR on a 7500 real-time PCR system
(Applied Biosystems) using iTaq SYBR Green Supermix (Bio-Rad). Data
were normalized relative to levels of GAPDH mRNA. Primers specific for
C9orf72 mRNA of all three variants are as follows: F 50-AGA AGG CAC AGA
GAG AAT GGA A-30; R 50-TCA TCA TCA TTG AGT ACT GTA TCA GC-30.
Primers for C9orf72 intron 1: F 50-ACG CCT GCA CAA TTT CAG CCC AA-30;
R 50-CAA GTC TGT GTC ATC TCG GAG CTG-30. Primers for GAPDH: F
50-GTC ATC AAT GGA AAT CCC ATC AC-30; R 50-TTC TCC ATG GTG GTG
AAG AC-30.
RNA Immunoprecipitation
RIP was performed as previously described with optimization (Hu et al., 2012).
Fibroblasts were seeded in 150-cm2 dishes (1,400,000/dish), and were trans-
fected with duplex RNAs in the next day. Cells (90% confluency) were har-
vested in 48 hr. Detached cells were lysed in a hypotonic lysis buffer (10 mM1510 Chemistry & Biology 22, 1505–1511, November 19, 2015 ª2015 Elsevier Ltd All rights reTris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2,
0.5% NP-40) with a volume about three times
the cell pellet size, gently pipetted up and down
to break up the pellet, then set on ice for 5 min, fol-
lowed by centrifugation (500 3 g) for 5 min to
collect the nuclei. The pellet was washed again
with hypotonic buffer for 5 min to remove all cyto-
plasmic components. The nuclei were lysed with
nuclear lysis buffer (20 mM Tris-HCl [pH 7.4],
150 mM KCl, 3 mM MgCl2, 0.5% NP-40, protease
inhibitor [EDTA-free; Roche] and RNase inhibitor
[Promega; 50 U/ml final]). The mixture was soni-
cated on ice for 20 s, three times, with 20%power.
After centrifugation, the supernatant was isolated
and stored at 80C.
60 ml of Protein A/G agarose Plus beads and
300 ml of nuclear lysate were incubated with 5 ml
of anti-AGO2 antibody (015-22031, Wako), or
mouse anti-immunoglobulin G antibody in 13
PBS (pH 7.4) at 4C with gentle agitation over-
night. The beads were washed with nuclear lysis
buffer twice, then eluted with elution buffer (1%
SDS, 0.1 M NaHCO3 and RNase inhibitor). After
proteinase K treatment, and RNA extraction andprecipitation, samples were treated with recombinant DNase I, followed by
reverse transcription. The enrichment of C9orf72 intron 1 levels were quanti-
fied by qPCR.
RNA FISH and Imaging
RNA FISH was performed following a Biosearch protocol with minor modifica-
tions. Fibroblast cells were plated at a density of 10,000/well into a Lab-Tek
8-well chambered coverglass slides. After 1 day, siRNA/lipid complex was
added at 50 nM final concentration. 48 hr after transfection, cells were fixed
with 4% formaldehyde in 13 PBS and permeabilized in 70% ethanol at 4C
overnight. Cells were washed with wash buffer (10% formamide in 23 saline
sodium citrate [SSC]) for 5 min, then incubated with pre-hybridization buffer
(40% formamide in 23 SSC) at 60C for 20min. A (CCCCGG)4-Cy3 DNA probe
or a (GGGGCC)3.3-Cy3 probe in hybridization buffer (100 mg/ml dextran sul-
fate and 40% formamide in 23 SSC) was added. The slide was placed in a
humidified chamber and incubated in the dark at 37C overnight. On the
next day, cells were washed twice with wash buffer at 37C, then stained
with mounting media with DAPI (Vector Labs, H-1500).
Cells were imaged at 603magnification using aWidefield Deltavisionmicro-
scope. Images were processed by blind deconvolution with AutoQuant X3.served
Visualization of RNA foci were made using ImageJ. For quantification, at
least 20 pictures were taken from randomly chosen microscopic fields, con-
taining 100–300 cells for each treatment. Counting of foci was performed by
different investigators. All data were generated by at least three independent
experiments.
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